The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of nivolumab in combination with talazoparib in unresectable or metastatic melanoma patients with mutations in BRCA or BRCAness.
 
Tamara A. Sussman
No Relationships to Disclose
 
Wei Wei
No Relationships to Disclose
 
Brian Hobbs
Stock and Other Ownership Interests - Presagia
Consulting or Advisory Role - Simulstat
Research Funding - Amgen
(OPTIONAL) Uncompensated Relationships - Presagia
 
C. Marcela Diaz-Montero
No Relationships to Disclose
 
Ying Ni
No Relationships to Disclose
 
Joshua Arbesman
Research Funding - Immune Pharmaceuticals
 
Jennifer S. Ko
No Relationships to Disclose
 
Brian Gastman
Consulting or Advisory Role - Quest Imaging
Speakers' Bureau - Castle Biosciences
Research Funding - Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Pauline Funchain
Consulting or Advisory Role - Eisai